# Alprostadil as an Adjuvant Therapy With Indirect Angiosomal Revascularization in Critical Limb Ischemia.

> **NCT04312555** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 30 (estimated)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **DRUG:** Alprostadil

## Key facts

- **NCT ID:** NCT04312555
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-01
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04312555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04312555, "Alprostadil as an Adjuvant Therapy With Indirect Angiosomal Revascularization in Critical Limb Ischemia.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04312555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*